Fosinopril decreases levels of soluble vascular cell adhesion molecule- 1 in type II diabetic patients suffering from microalbuminuria [1]

Diabetologia

Volumn 41, Issue 8, 1998, Pages 980-981

  Gasic, S ^a   Wagner, O F ^a   Fasching, D ^a   Ludwig, C ^a   Veitl, M ^a   Kapiotis, S ^a   Jilma, B ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOSINOPRIL; INSULIN;

ADULT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INDICATION; DRUG MECHANISM; FEMALE; HUMAN; LETTER; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TREATMENT OUTCOME;

ALBUMINURIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DIABETES MELLITUS, TYPE 2; FEMALE; FOSINOPRIL; HUMANS; MALE; MIDDLE AGED; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0031867586     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051017     Document Type: Letter

References (12)